Citations for
1LXN
Latexin deficiency attenuates adipocyte differentiation and protects mice against obesity and metabolic disorders induced by high-fat diet.
Kan S, Li R, Tan Y, Yang F, Xu S, Wang L, Zhang L, Sun X, Chen X, Yang Y, Shu W, Wan H, Chen ZF, Liang H, Chen M.
Cell Death Dis. Feb 24;13(2):175. doi: 10.1038/s41419-022-04636-9. 2022
2FLNA, LXN
LXN deficiency regulates cytoskeleton remodelling by promoting proteolytic cleavage of Filamin A in vascular endothelial cells
He G, Kan S, Xu S, Sun X, Li R, Shu W, Chen M.
J Cell Mol Med. Jul;25(14):6815-6827. doi: 10.1111/jcmm.16685. Epub 2021 Jun 3. 2021
3LXN
The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy
Seed RI, Taurozzi AJ, Wilcock DJ, Nappo G, Erb HHH, Read ML, Gurney M, Archer LK, Ito S, Rumsby MG, Petrie JL, Clayton A, Maitland NJ, Collins AT.
Sci Rep. Mar 26;9(1):5120. doi: 10.1038/s41598-019-41379-8. 2019
4LXN
Latexin Inactivation Enhances Survival and Long-Term Engraftment of Hematopoietic Stem Cells and Expands the Entire Hematopoietic System in Mice.
Liu Y, Zhang C, Li Z, Wang C, Jia J, Gao T, Hildebrandt G, Zhou D, Bondada S, Ji P, St Clair D, Liu J, Zhan C, Geiger H, Wang S, Liang Y.
Stem Cell Reports. Apr 11;8(4):991-1004. doi: 10.1016/j.stemcr.2017.02.009. Epub 2017 Mar 16 2017
5LXN, PROM1
Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma.
Xue Z, Zhou Y, Wang C, Zheng J, Zhang P, Zhou L, Wu L, Shan Y, Ye M, He Y, Cai Z.
Oncol Rep. Jan;35(1):50-8. doi: 10.3892/or.2015.4353. Epub 2015 Oct 27. 2015
6LXN
Latexin exhibits tumor suppressor potential in hepatocellular carcinoma.
Ni QF, Tian Y, Kong LL, Lu YT, Ding WZ, Kong LB.
Oncol Rep. Mar;31(3):1364-72. doi: 10.3892/or.2014.2966. Epub 2014 Jan 8. 2014
7LXN, RARRES1
Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN. 2013 PMID:
Oldridge EE, Walker HF, Stower MJ, Simms MS, Mann VM, Collins AT, Pellacani D, Maitland NJ.
Oncogenesis Apr 15;2(4):e45. doi: 10.1038/oncsis.2013.6. 2013
8LXN
Latexin regulates the abundance of multiple cellular proteins in hematopoietic stem cells
Mitsunaga K, Kikuchi J, Wada T, Furukawa Y.
J Cell Physiol. Mar;227(3):1138-47. doi: 10.1002/jcp.22834. 2012
9BMP2, LXN
Latexin is involved in bone morphogenetic protein-2-induced chondrocyte differentiation.
Kadouchi I, Sakamoto K, Tangjiao L, Murakami T, Kobayashi E, Hoshino Y, Yamaguchi A.
Biochem Biophys Res Commun 378(3):600-4. Epub 2008 Dec 4. 2009
10LXN
Latexin is a newly discovered regulator of hematopoietic stem cells.
de Haan G.
Nat Genet 39(2):141-2. 2007
11LXN
The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice.
Liang Y, Jansen M, Aronow B, Geiger H, Van Zant G.
Nat Genet 39(2):178-88. Epub 2007 Jan 14. 2007
12CPA4, LXN
Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin.
Pallares I, Bonet R, Garcia-Castellanos R, Ventura S, Aviles FX, Vendrell J, Gomis-Ruth FX.
Proc Natl Acad Sci U S A 102(11):3978-83. Epub 2005 Feb 28. 2005
13LXN
Cloning, tissue expression pattern and genomic organization of latexin, a human homologue of rat carboxypeptidase A inhibitor.
Liu Q, Yu L, Gao J, Fu Q, Zhang J, Zhang P, Chen J, Zhao S.
Mol Biol Rep 27(4):241-6. 2000
14LXN
Genomic organization and regulatory elements of the rat latexin gene, which is expressed in a cell type-specific manner in both central and peripheral nervous systems.
Miyasaka N, Hatanaka Y, Jin M, Arimatsu Y.
Brain Res Mol Brain Res 69(1):62-72. 1999